Patents by Inventor David J. Kemp

David J. Kemp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amplified DNA assay using a double stranded DNA binding protein
    Patent number: 5536648
    Abstract: A method for capturing amplified target DNA on a solid substrate comprising incorporating a ligand into said DNA by a polymerase chain reaction using a set of primers wherein one of the primers bears the ligand, and contacting the so treated DNA with a solid substrate having a binding reagent for said ligand immobilized thereon.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: July 16, 1996
    Assignee: Amrad Corporation Limited
    Inventors: David J. Kemp, Simon J. Foote, Michael G. Peterson, Nicholas Samaras, Donald Smith
  • The RESA and FIRA antigens of plasmodium falciparum
    Patent number: 5126264
    Abstract: DNA molecules comprising polynucleotide sequences substantially corresponding to all or a portion of the base sequence coding for an antigen of Plasmodium falciparum selected from the group consisting of the RESA antigen, the FIRA antigen, and other antigens of P. falciparum cross-reactive therewith. Such DNA molecules are capable of being expressed as polypeptide(s). Synthetic peptides or polypeptides displaying the antigenicity of all or a portion of the RESA or FIRA antigens of P. falciparum. Compositions for stimulating immune responses against P. falciparum antigens in a mammal, comprising at least one polypeptide displaying the antigenicity of the RESA or FIRA antigens of P. falciparum.
    Type: Grant
    Filed: July 16, 1990
    Date of Patent: June 30, 1992
    Assignee: The Walter & Eliza Hall Institute of Medical Research
    Inventors: David J. Kemp, Robin F. Anders, Ross Coppel, Graham V. Brown, Robert B. Saint, Alan E. Cowman, Albert E. Bianco, Graham F. Mitchell
  • Asexual blood stage antigens of Plasmodium falciparum which encode a rhoptry protein
    Patent number: 5116755
    Abstract: DNA molecules comprising artificially constructed polynucleotide sequences substantially coresponding to all or a portion of the base sequence coding for an antigen of Plasmodium faliciparum selected from the group consisting of the Acidic Basic Repeat Antigen Rhoptry (ABRA), the antigen of any of clones Ag 169, Ag303, Ag358, Ag361, Ag372, Ag394 or Ag501, defined herein, and other antigens of P. falciparum cross-reactive therewith. Such DNA molecules are capable of being expressed as polypeptide(s). Synthetic peptides or polypeptides displaying the antigenicity of all or a portion of the above antigens of P. falciparum. Compositions for stimulating immune responses against P. falciparum antigens in a mammal, comprising at least one polyupeptide displaying the antigenicity of the above antigens of P. falciparum, together with a pharmaceutically acceptable carrier therefor.
    Type: Grant
    Filed: August 25, 1987
    Date of Patent: May 26, 1992
    Inventors: David J. Kemp, Robin F. Anders, Ross L. Coppel, Graham V. Brown